News
Valneva and Pfizer report Lyme disease antibody data
Pfizer has reported antibody persistence data six months after the completion of a two to three-dose vaccination schedule.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Pfizer has reported antibody persistence data six months after the completion of a two to three-dose vaccination schedule.